Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 883 citing articles:

Single-cell transcriptomic analysis of Alzheimer’s disease
Hansruedi Mathys, José Dávila-Velderrain, Zhuyu Peng, et al.
Nature (2019) Vol. 570, Iss. 7761, pp. 332-337
Open Access | Times Cited: 2035
Reactive astrocyte nomenclature, definitions, and future directions
Carole Escartin, Elena Galea, András Lakatos, et al.
Nature Neuroscience (2021) Vol. 24, Iss. 3, pp. 312-325
Open Access | Times Cited: 1680
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
Yu Yamazaki, Na Zhao, Thomas R. Caulfield, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 9, pp. 501-518
Open Access | Times Cited: 1045
The Amyloid-β Pathway in Alzheimer’s Disease
Harald Hampel, John Hardy, Kaj Blennow, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 10, pp. 5481-5503
Open Access | Times Cited: 1041
A single-cell atlas of entorhinal cortex from individuals with Alzheimer’s disease reveals cell-type-specific gene expression regulation
Alexandra Grubman, Gabriel Chew, John F. Ouyang, et al.
Nature Neuroscience (2019) Vol. 22, Iss. 12, pp. 2087-2097
Closed Access | Times Cited: 782
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Tiantian Guo, Denghong Zhang, Yuzhe Zeng, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 703
APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches
Alberto Serrano‐Pozo, Sudeshna Das, Bradley T. Hyman
The Lancet Neurology (2020) Vol. 20, Iss. 1, pp. 68-80
Open Access | Times Cited: 652
A brief history of human disease genetics
Melina Claussnitzer, Judy H. Cho, Rory Collins, et al.
Nature (2020) Vol. 577, Iss. 7789, pp. 179-189
Open Access | Times Cited: 610
Role of neuroinflammation in neurodegeneration development
Weifeng Zhang, Dan Xiao, Qinwen Mao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 555
TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge
Alicia Nugent, Karin Lin, Bettina van Lengerich, et al.
Neuron (2020) Vol. 105, Iss. 5, pp. 837-854.e9
Open Access | Times Cited: 519
A research agenda for ageing in China in the 21st century (2nd edition): Focusing on basic and translational research, long-term care, policy and social networks
Evandro Fei Fang, Chenglong Xie, Joseph Adam Schenkel, et al.
Ageing Research Reviews (2020) Vol. 64, pp. 101174-101174
Open Access | Times Cited: 460
Amyloid-β-independent regulators of tau pathology in Alzheimer disease
Rik van der Kant, Lawrence S.B. Goldstein, Rik Ossenkoppele
Nature reviews. Neuroscience (2019) Vol. 21, Iss. 1, pp. 21-35
Closed Access | Times Cited: 448
A Quarter Century of APOE and Alzheimer’s Disease: Progress to Date and the Path Forward
Michaël E. Belloy, Valerio Napolioni, Michael D. Greicius
Neuron (2019) Vol. 101, Iss. 5, pp. 820-838
Open Access | Times Cited: 441
The multiplex model of the genetics of Alzheimer’s disease
Rebecca Sims, Matthew Hill, Julie Williams
Nature Neuroscience (2020) Vol. 23, Iss. 3, pp. 311-322
Open Access | Times Cited: 401
Modeling Alzheimer’s disease with iPSC-derived brain cells
Jay Penney, William T. Ralvenius, Li‐Huei Tsai
Molecular Psychiatry (2019) Vol. 25, Iss. 1, pp. 148-167
Open Access | Times Cited: 367
Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future
Yun Zhang, Huaqiu Chen, Ran Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 364
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Ana‐Caroline Raulin, Sydney V. Doss, Zachary A. Trottier, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 335
CRISPR/Cas9 therapeutics: progress and prospects
Tianxiang Li, Yanyan Yang, Hongzhao Qi, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 307
APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes
Joel Blanchard, Leyla Anne Akay, José Dávila-Velderrain, et al.
Nature (2022) Vol. 611, Iss. 7937, pp. 769-779
Open Access | Times Cited: 294
15 years of GWAS discovery: Realizing the promise
Abdel Abdellaoui, Loïc Yengo, Karin J. H. Verweij, et al.
The American Journal of Human Genetics (2023) Vol. 110, Iss. 2, pp. 179-194
Open Access | Times Cited: 293
The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications
Amaia M. Arranz, Bart De Strooper
The Lancet Neurology (2019) Vol. 18, Iss. 4, pp. 406-414
Open Access | Times Cited: 290
Building Models of Brain Disorders with Three-Dimensional Organoids
Neal D. Amin, Sergiu P. Paşca
Neuron (2018) Vol. 100, Iss. 2, pp. 389-405
Open Access | Times Cited: 286
Long-term maturation of human cortical organoids matches key early postnatal transitions
Aaron Gordon, Se‐Jin Yoon, Stephen Tran, et al.
Nature Neuroscience (2021) Vol. 24, Iss. 3, pp. 331-342
Open Access | Times Cited: 276
Astrocyte Biomarkers in Alzheimer’s Disease
Stephen F. Carter, Karl Herholz, Pedro Rosa‐Neto, et al.
Trends in Molecular Medicine (2019) Vol. 25, Iss. 2, pp. 77-95
Closed Access | Times Cited: 268
Microglia: Agents of the CNS Pro-Inflammatory Response
José A. Rodríguez‐Gómez, Edel Kavanagh, Pinelopi Engskog-Vlachos, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1717-1717
Open Access | Times Cited: 264
Page 1 - Next Page

Scroll to top